NASONEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nasonex, and what generic alternatives are available?
Nasonex is a drug marketed by Organon Llc and Perrigo Pharma Intl and is included in two NDAs.
The generic ingredient in NASONEX is mometasone furoate. There are thirty drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the mometasone furoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nasonex
A generic version of NASONEX was approved as mometasone furoate by PADAGIS US on March 18th, 2002.
Summary for NASONEX
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 60 |
Patent Applications: | 5,359 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for NASONEX |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for NASONEX |
What excipients (inactive ingredients) are in NASONEX? | NASONEX excipients list |
DailyMed Link: | NASONEX at DailyMed |
Recent Clinical Trials for NASONEX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yingu Pharmaceutical Co., Ltd | Phase 4 |
Centre hospitalier de l'Université de Montréal (CHUM) | Phase 4 |
EMS | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for NASONEX
Paragraph IV (Patent) Challenges for NASONEX
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
NASONEX | Nasal Spray | mometasone furoate | 50 mcg/ Spray | 020762 | 1 | 2009-08-07 |
US Patents and Regulatory Information for NASONEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Perrigo Pharma Intl | NASONEX 24HR ALLERGY | mometasone furoate | SPRAY, METERED;NASAL | 215712-001 | Mar 17, 2022 | OTC | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NASONEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Organon Llc | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NASONEX
See the table below for patents covering NASONEX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 9100990 | COMPUESTO MONOHIDRATO DE FUROATO DE MOMETASONA,AL PROCEDIMIENTO PARA SU PREPARACION Y A LAS COMPOSICIONES FARMACEUTICAS | ⤷ Try a Trial |
Czech Republic | 281318 | Monohydrát mometasonfuroátu, způsob přípravy této látky a přípravy lékových kompozic z ní (MONOHYDRATE OF 9 ALPHA, 21-DICHLORO-16 ALPHA-METHYL-1,4-PREGNADIENE-11 BETA, 17 ALPHA-DIOL-3,20-DIONE-17-(2°-FUROATE), PROCESS OF ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF) | ⤷ Try a Trial |
African Intellectual Property Organization (OAPI) | 7116 | ⤷ Try a Trial | |
Denmark | 39082 | ⤷ Try a Trial | |
Australia | 7991882 | ⤷ Try a Trial | |
Japan | 2008031184 | USE OF MOMETASONE FUROATE FOR TREATING AIRWAY PASSAGE AND LUNG DISEASE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NASONEX
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0548114 | 19875032 | Germany | ⤷ Try a Trial | PRODUCT NAME: MOMETASON-FUROAT-MONOHYDRAT; NAT. REGISTRATION NO/DATE: 40803.00.00 19980218; FIRST REGISTRATION: FRANKREICH NL 22055 19970219 |
0057401 | 94C0004 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT REG.: 304 S 133 F 7 19930813; FIRST REG.: GR 10682/89 19900622 |
0057401 | 94C0002 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONI FUROAS; NAT. REG.: 304 S 131 F 7 19930813; FIRST REG.: GR 10681/89 19900622 |
3043773 | 2022C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
0548114 | 980012 | Netherlands | ⤷ Try a Trial | 980012, 20110905, EXPIRES: 20160905 |
0548114 | SPC/GB97/064 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |